Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory Molecules
Open Access
- 1 May 2007
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 15 (5), 981-988
- https://doi.org/10.1038/mt.sj.6300134
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cellsLeukemia, 2006
- The role of CD8+ T‐cell replicative senescence in human agingImmunological Reviews, 2005
- Dendritic cells as therapeutic vaccines against cancerNature Reviews Immunology, 2005
- Tolerogenic Dendritic CellsAnnual Review of Immunology, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BBNature Biotechnology, 2002
- IgG Fc ReceptorsAnnual Review of Immunology, 2001
- Response Differences between Human CD4+ and CD8+ T-Cells during CD28 Costimulation: Implications for Immune Cell-Based Therapies and Studies Related to the Expansion of Double-Positive T-Cells during AgingClinical Immunology, 2000
- Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cellsJCI Insight, 1999
- Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering of dendritic cells and T lymphocytes.The Journal of Experimental Medicine, 1987